Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 02, 2022

SELL
$11.57 - $15.59 $66,469 - $89,564
-5,745 Reduced 97.84%
127 $2,000
Q2 2022

Aug 09, 2022

BUY
$8.45 - $14.84 $48,545 - $85,255
5,745 Added 4523.62%
5,872 $82,000
Q3 2021

Nov 05, 2021

BUY
$25.71 - $35.24 $1,491 - $2,043
58 Added 84.06%
127 $3,000
Q4 2020

Feb 04, 2021

BUY
$23.42 - $39.5 $1,615 - $2,725
69 New
69 $2,000

Others Institutions Holding RPTX

About Repare Therapeutics Inc.


  • Ticker RPTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 41,937,800
  • Market Cap $119M
  • Description
  • Repare Therapeutics Inc., a clinical-stage precision oncology company, discovers and develops therapeutics by using its synthetic lethality approach in Canada and the United States. The company uses its SNIPRx, a proprietary, genome-wide, and CRISPR-enabled platform to systematically discover and develop highly targeted cancer therapies that foc...
More about RPTX
Track This Portfolio

Track Daiwa Securities Group Inc. Portfolio

Follow Daiwa Securities Group Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Daiwa Securities Group Inc., based on Form 13F filings with the SEC.

News

Stay updated on Daiwa Securities Group Inc. with notifications on news.